NeuroSense Therapeutics Ltd.

NRSN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001875091

SEC filings (opens in a new tab)

No open-market purchases or sales by NeuroSense Therapeutics Ltd. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $285.7K in total; no superinvestor holds it.

Other share classesNRSNW

Superinvestors holding NRSN, Q2 2026

See all superinvestors

No superinvestor reported holding NRSN in Q2 2026.